Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

AB SCIEX Launches CE Marked IVD-MS™ Analyzer for Hospitals and Diagnostic Laboratories in Europe

Published: Tuesday, November 26, 2013
Last Updated: Tuesday, November 26, 2013
Bookmark and Share
The first-in-class, complete analyzer is based on LC/MS/MS technology meeting European regulatory requirements.

Continuing to rapidly expand its presence in the clinical diagnostics field, AB SCIEX, a global leader in analytical technologies, today announced the launch of its AB SCIEX IVD-MS™ Analyzer CE marked for general in vitro diagnostic use in Europe.*

The release of this mass spectrometry-based analyzer is in response to growing demand within hospitals and clinical diagnostic laboratories for faster, more accurate results than what is currently achievable with the most commonly used analyzers in the majority of diagnostic facilities today.  

“We have redefined what a mass spectrometry analyzer is capable of doing for in vitro diagnostics,” said Rainer Blair, President of AB SCIEX.  “By combining the peace of mind of proven technology with the latest advancements in the user interface and integrated software development, we are making LC/MS/MS technologies as easy to use as ever in a clinical lab.  Now available to a significant number of European clinical laboratories is the ability to improve the quality of in vitro diagnostic results while reducing costs compared to other technologies.”  

The new AB SCIEX IVD-MS™ Analyzer provides a combination of the high sensitivity and selectivity of mass spectrometry (MS) technology and the molecular separation power of liquid chromatography (LC) with a technician-friendly, intuitive interface.

AB SCIEX, which has been highly successful in the research (RUO) market for decades, has re-engineered its software application specifically for medical technologists, making the user interface more intuitive, simpler to navigate and ideal for new users in fast-paced clinical settings.  
The new SCIEX ClearCore™ MD Software provides streamlined data processing, reporting and review functionality.   This will help make the adoption of LC/MS/MS for routine analysis significantly easier.  

The ClearCore software enables quantitation and data exploration without the need for additional software packages. It provides simple method development tools with separate LC and MS method editors.  It also provides customizable access to modules based on user security levels, including routine users, method developers, data reviewers and administrators, so personnel is only able to access approved modules. This software drives the workflow that utilizes the power of the analyzer.  

The new IVD-MS™ Analyzer joins the company’s growing line of in vitro diagnostic devices for certain European countries, including the AB SCIEX 3200MD CE-IVD series of MS systems – the API 3200MD™ and 3200MD QTRAP® LC/MS/MS systems –  launched earlier in 2013.  The new analyzer utilizes the company’s state-of-the-art LC and MS technologies that have a proven track record with AB SCIEX customers.  

The intended use of this regulatory-compliant device is to identify inorganic or organic compounds in human specimens for clinical use, providing routine diagnostic testing laboratories in certain countries in Europe with the ability to quantitate multiple trace level compounds in a single analysis with high confidence in the results.

The company plans to extend its in vitro diagnostic solutions into other parts of the world in the future.  

*Only available in select European regions at this time, not available in other countries.  For more information contact your local AB SCIEX representative.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

AB SCIEX Wins New Product Innovation Award in Asia Pacific
The award recognizes the company’s continued innovation in the mass spectrometry industry and a number of new products introduced into the market in recent years.
Thursday, October 30, 2014
AB SCIEX Receives Frost & Sullivan Award
AB SCIEX has been awarded the 2013 Global Market Share Leadership Award for Mass Spectrometry from Frost & Sullivan.
Thursday, September 12, 2013
AB SCIEX Announces In Vitro Diagnostic Devices CE Marked for Europe
AB SCIEX launches the 3200MD CE-IVDD series for general in vitro diagnostic use in Europe.
Tuesday, May 21, 2013
AB SCIEX Achieves ISO 13485 Certification for Manufacturing of LC/MS Systems
This ISO certification is often considered a first step toward complying with European regulatory requirements for a device to be cleared for use in the clinic.
Monday, February 27, 2012
Scientific News
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
Making Virus Sensors Cheap and Simple
Researchers at The University of Texas at Austin demonstrated the ability to detect single viruses in a solution containing murine cytomegalovirus (MCMV).
Heart Defect Prediction Technology Could Lead to Earlier, More Informed Treatment
Experimental method uses genetics-guided biomechanics, patient-specific stem cells.
Biosensor Detects Molecules Linked to Cancer, Alzheimer's and Parkinson's
Novel biosensor has been proven capable of detecting molecules associated with neurodegenerative diseases and some types of cancer.
Big Data Can Save Lives
The sharing of genetic information from millions of cancer patients around the world could be key to revolutionising cancer prevention and care, according to a leading cancer expert from Queen's University Belfast.
Fast, Simple Test for Colitis
A minimally invasive screening for ulcerative colitis using emerging infrared technology could be a rapid and cost-effective method for detecting disease that eliminates the need for biopsies and intrusive testing of the human body.
Scans Reveal Babies of Mothers with Gestational Diabetes Have More Body Fat
Researchers at Imperial College London have found that the babies born to mothers with gestational diabetes have more body fat at two months of age compared to babies born to healthy mothers.
New Device Could Improve Cancer Detection
UBC researchers develop a microfluidic device to capture circulating tumor cells.
Plasma Biomarkers for Breast Cancer Diagnosis
Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!